These histological data were supported by a significant reduction in the levels of MPO, TNFα, IL-1, and IL-17 in AS-Ag-NP-treated IPA mice as compared to control IPA mice (Figure 5C–F). This evidence concerns the gene MPO and Ito hypomelanosis.